The biology and therapeutic targeting of the proprotein convertases

[1]  N. Seidah.  Proprotein Convertase 2 , 2013 .

[2]  D. Rao,et al.  Phase I Trial of "bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell" Vaccine (FANG) in Advanced Cancer. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  I. Lindberg,et al.  Inhibition of Prohormone Convertases PC1/3 and PC2 by 2,5-Dideoxystreptamine Derivatives , 2012, Molecular Pharmacology.

[4]  A. Prat,et al.  Gene Inactivation of Proprotein Convertase Subtilisin/Kexin Type 9 Reduces Atherosclerosis in Mice , 2012, Circulation.

[5]  N. Seidah,et al.  SKI-1 and Furin generate multiple RGMa fragments that regulate axonal growth. , 2012, Developmental Cell.

[6]  N. Geoghagen,et al.  An Anti-PCSK9 Antibody Reduces LDL-Cholesterol On Top Of A Statin And Suppresses Hepatocyte SREBP-Regulated Genes , 2012, International journal of biological sciences.

[7]  S. Kunz,et al.  Evaluation of the anti-arenaviral activity of the subtilisin kexin isozyme-1/site-1 protease inhibitor PF-429242. , 2012, Virology.

[8]  M. Lindholm,et al.  PCSK9 LNA antisense oligonucleotides induce sustained reduction of LDL cholesterol in nonhuman primates. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  Jason C. Ho,et al.  Adamts5 (aggrecanase‐2) is widely expressed in the mouse musculoskeletal system and is induced in specific regions of knee joint explants by inflammatory cytokines , 2012, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[10]  J. Chaparro-Riggers,et al.  Proprotein Convertase Substilisin/Kexin Type 9 Antagonism Reduces Low-Density Lipoprotein Cholesterol in Statin-Treated Hypercholesterolemic Nonhuman Primates , 2012, Journal of Pharmacology and Experimental Therapeutics.

[11]  J. Creemers,et al.  Internalization of Proprotein Convertase PC7 from Plasma Membrane Is Mediated by a Novel Motif* , 2012, The Journal of Biological Chemistry.

[12]  P. Elliott,et al.  Heterozygous Mutations Causing Partial Prohormone Convertase 1 Deficiency Contribute to Human Obesity , 2012, Diabetes.

[13]  Sarah Crunkhorn.  Trial watch: PCSK9 antibody reduces LDL cholesterol , 2012, Nature Reviews Drug Discovery.

[14]  S. Dixit,et al.  Human Subtilase SKI-1/S1P Is a Master Regulator of the HCV Lifecycle and a Potential Host Cell Target for Developing Indirect-Acting Antiviral Agents , 2012, PLoS pathogens.

[15]  R Bailén Almorox,et al.  [Effect of a monoclonal antibody to PCSK9 on LDL cholesterol]. , 2012, Revista clinica espanola.

[16]  P. Ridker,et al.  Rosuvastatin, proprotein convertase subtilisin/kexin type 9 concentrations, and LDL cholesterol response: the JUPITER trial. , 2012, Clinical chemistry.

[17]  K. Tomita,et al.  Proteolytic activation of the epithelial sodium channel and therapeutic application of a serine protease inhibitor for the treatment of salt-sensitive hypertension , 2012, Clinical and Experimental Nephrology.

[18]  S. Opal,et al.  Proprotein convertases in health and disease. , 2011, The New England journal of medicine.

[19]  V. Hytönen,et al.  Identification of proprotein convertase substrates using genome-wide expression correlation analysis , 2011, BMC Genomics.

[20]  E. Settembre,et al.  Mechanistic implications for LDL receptor degradation from the PCSK9/LDLR structure at neutral pH , 2011, EMBO reports.

[21]  T. Kambayashi,et al.  Cellular therapies supplement: the role of granulocyte macrophage colony‐stimulating factor and dendritic cells in regulatory T‐cell homeostasis and expansion , 2011, Transfusion.

[22]  J. Long,et al.  The metabolic serine hydrolases and their functions in mammalian physiology and disease. , 2011, Chemical reviews.

[23]  Robert Day,et al.  On the cutting edge of proprotein convertase pharmacology: from molecular concepts to clinical applications , 2011, Biomolecular concepts.

[24]  L. Bernier,et al.  Novel loss-of-function PCSK9 variant is associated with low plasma LDL cholesterol in a French-Canadian family and with impaired processing and secretion in cell culture. , 2011, Clinical chemistry.

[25]  Christian Gieger,et al.  Genetic Variants in Novel Pathways Influence Blood Pressure and Cardiovascular Disease Risk , 2011, Nature.

[26]  D. Constam,et al.  The microenvironment patterns the pluripotent mouse epiblast through paracrine Furin and Pace4 proteolytic activities. , 2011, Genes & development.

[27]  Michael Nilges,et al.  Computational Reverse-Engineering of a Spider-Venom Derived Peptide Active Against Plasmodium falciparum SUB1 , 2011, PloS one.

[28]  M. Schweizer,et al.  A Key Enzyme in the Biogenesis of Lysosomes Is a Protease That Regulates Cholesterol Metabolism , 2011, Science.

[29]  A. Prat,et al.  Latent Transforming Growth Factor β-Binding Proteins-2 and -3 Inhibit the Proprotein Convertase 5/6A* , 2011, The Journal of Biological Chemistry.

[30]  A. Prat,et al.  Inactivation of endothelial proprotein convertase 5/6 decreases collagen deposition in the cardiovascular system: role of fibroblast autophagy , 2011, Journal of Molecular Medicine.

[31]  D. Patra,et al.  Site-1 Protease Is Essential to Growth Plate Maintenance and Is a Critical Regulator of Chondrocyte Hypertrophic Differentiation in Postnatal Mice* , 2011, The Journal of Biological Chemistry.

[32]  C. Le May,et al.  Clinical aspects of PCSK9. , 2011, Atherosclerosis.

[33]  I. Fournier,et al.  Molecular Validation of PACE4 as a Target in Prostate Cancer. , 2011, Translational oncology.

[34]  Annik Prat,et al.  Furin Is the Major Processing Enzyme of the Cardiac-specific Growth Factor Bone Morphogenetic Protein 10* , 2011, The Journal of Biological Chemistry.

[35]  A. Prat,et al.  Circulating Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Regulates VLDLR Protein and Triglyceride Accumulation in Visceral Adipose Tissue , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[36]  N. Seidah.  What lies ahead for the proprotein convertases? , 2011, Annals of the New York Academy of Sciences.

[37]  Toshiko Tanaka,et al.  Novel association to the proprotein convertase PCSK7 gene locus revealed by analysing soluble transferrin receptor (sTfR) levels. , 2011, Human molecular genetics.

[38]  Guoqing Cao,et al.  Effects of currently prescribed LDL-C-lowering drugs on PCSK9 and implications for the next generation of LDL-C-lowering agents , 2011, Lipids in Health and Disease.

[39]  N. Hooper,et al.  PCSK9: an emerging target for treatment of hypercholesterolemia , 2011, Expert opinion on therapeutic targets.

[40]  N. Seidah,et al.  Proprotein Convertase PC7 Enhances the Activation of the EGF Receptor Pathway through Processing of the EGF Precursor* , 2011, The Journal of Biological Chemistry.

[41]  Lora Hamuro,et al.  A PCSK9-binding antibody that structurally mimics the EGF(A) domain of LDL-receptor reduces LDL cholesterol in vivo1[S] , 2011, Journal of Lipid Research.

[42]  A. Morris,et al.  PCSK6 is associated with handedness in individuals with dyslexia , 2010, Human molecular genetics.

[43]  M. Chrétien.  The prohormone theory and the proprotein convertases: it is all about serendipity. , 2011, Methods in molecular biology.

[44]  D. Steiner.  On the discovery of precursor processing. , 2011, Methods in molecular biology.

[45]  N. Seidah.  The proprotein convertases, 20 years later. , 2011, Methods in molecular biology.

[46]  N. Seidah,et al.  Proprotein Convertases , 2011, Methods in Molecular Biology.

[47]  A. Prat,et al.  In Vivo Evidence That Furin from Hepatocytes Inactivates PCSK9* , 2010, The Journal of Biological Chemistry.

[48]  N. Seidah,et al.  The Proprotein Convertase PC7 , 2010, The Journal of Biological Chemistry.

[49]  R. Midura,et al.  Inhibition of Proprotein Convertase SKI-1 Blocks Transcription of Key Extracellular Matrix Genes Regulating Osteoblastic Mineralization* , 2010, The Journal of Biological Chemistry.

[50]  S. Kunz,et al.  Antiviral Activity of a Small-Molecule Inhibitor of Arenavirus Glycoprotein Processing by the Cellular Site 1 Protease , 2010, Journal of Virology.

[51]  D. Constam,et al.  Imaging proprotein convertase activities and their regulation in the implanting mouse blastocyst , 2010, The Journal of cell biology.

[52]  K. Berge,et al.  Disrupted recycling of the low density lipoprotein receptor by PCSK9 is not mediated by residues of the cytoplasmic domain. , 2010, Molecular genetics and metabolism.

[53]  Nan-fang Li,et al.  Associations between genetic variations in the FURIN gene and hypertension , 2010, BMC Medical Genetics.

[54]  N. Seidah,et al.  The Influence of PCSK9 Polymorphisms on Serum Low-Density Lipoprotein Cholesterol and Risk of Atherosclerosis , 2010, Current atherosclerosis reports.

[55]  Xiaorong Zhu,et al.  Analysis of peptides in prohormone convertase 1/3 null mouse brain using quantitative peptidomics , 2010, Journal of neurochemistry.

[56]  A. Klein-Szanto,et al.  Proprotein convertase inhibition results in decreased skin cell proliferation, tumorigenesis, and metastasis. , 2010, Neoplasia.

[57]  O. Pedersen,et al.  Obesity‐related Polymorphisms and Their Associations With the Ability to Regulate Fat Oxidation in Obese Europeans: The NUGENOB Study , 2010, Obesity.

[58]  A. Soutar,et al.  Increased Secretion of Lipoproteins in Transgenic Mice Expressing Human D374Y PCSK9 Under Physiological Genetic Control , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[59]  A. Basak,et al.  Proprotein convertase inhibitory activities of flavonoids isolated from Oroxylum indicum. , 2010, Current medicinal chemistry.

[60]  D. Rader,et al.  Angiopoietin-like Protein 3 Inhibits Lipoprotein Lipase Activity through Enhancing Its Cleavage by Proprotein Convertases* , 2010, The Journal of Biological Chemistry.

[61]  N. Seidah,et al.  A Locked Nucleic Acid Antisense Oligonucleotide (LNA) Silences PCSK9 and Enhances LDLR Expression In Vitro and In Vivo , 2010, PloS one.

[62]  A. Grodzinsky,et al.  Transport and equilibrium uptake of a peptide inhibitor of PACE4 into articular cartilage is dominated by electrostatic interactions. , 2010, Archives of biochemistry and biophysics.

[63]  D. Steiner,et al.  Neuropeptidomic analysis establishes a major role for prohormone convertase‐2 in neuropeptide biosynthesis , 2010, Journal of neurochemistry.

[64]  Annik Prat,et al.  PCSK9‐deficient mice exhibit impaired glucose tolerance and pancreatic islet abnormalities , 2010, FEBS letters.

[65]  J. Condra,et al.  A Proprotein Convertase Subtilisin-like/Kexin Type 9 (PCSK9) C-terminal Domain Antibody Antigen-binding Fragment Inhibits PCSK9 Internalization and Restores Low Density Lipoprotein Uptake , 2010, The Journal of Biological Chemistry.

[66]  I. Lindberg,et al.  Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics. , 2010, Journal of medicinal chemistry.

[67]  K. Berge,et al.  A chimeric LDL receptor containing the cytoplasmic domain of the transferrin receptor is degraded by PCSK9. , 2010, Molecular genetics and metabolism.

[68]  Helen J. Curtis,et al.  Different Mechanisms of Recognition and ER Retention by Transmembrane Transcription Factors CREB‐H and ATF6 , 2010, Traffic.

[69]  L. Bernier,et al.  A new method for measurement of total plasma PCSK9: clinical applications , 2010, Journal of Lipid Research.

[70]  Neil D. Rawlings,et al.  MEROPS: the peptidase database , 2009, Nucleic Acids Res..

[71]  J. Schiller,et al.  The role of furin in papillomavirus infection. , 2009, Future microbiology.

[72]  A. Prat,et al.  Genetic Variation at the Proprotein Convertase Subtilisin/Kexin Type 5 Gene Modulates High-Density Lipoprotein Cholesterol Levels , 2009, Circulation. Cardiovascular genetics.

[73]  Annik Prat,et al.  The proprotein convertase PC5/6 is protective against intestinal tumorigenesis: in vivo mouse model , 2009, Molecular Cancer.

[74]  Jianghong Rao,et al.  In vivo bioluminescence imaging of furin activity in breast cancer cells using bioluminogenic substrates. , 2009, Bioconjugate chemistry.

[75]  D. Constam.  Running the gauntlet: an overview of the modalities of travel employed by the putative morphogen Nodal. , 2009, Current opinion in genetics & development.

[76]  A. Prat,et al.  Dissection of the Endogenous Cellular Pathways of PCSK9-induced Low Density Lipoprotein Receptor Degradation , 2009, The Journal of Biological Chemistry.

[77]  Jonathan C. Cohen,et al.  Genetic and metabolic determinants of plasma PCSK9 levels. , 2009, The Journal of clinical endocrinology and metabolism.

[78]  A. Prat,et al.  PCSK9 impedes hepatitis C virus infection in vitro and modulates liver CD81 expression , 2009, Hepatology.

[79]  Yan Wang,et al.  A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates , 2009, Proceedings of the National Academy of Sciences.

[80]  J. Horton,et al.  Antagonism of Secreted PCSK9 Increases Low Density Lipoprotein Receptor Expression in HepG2 Cells* , 2009, Journal of Biological Chemistry.

[81]  A. Munnich,et al.  Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease , 2009, Human mutation.

[82]  Jonathan C. Cohen,et al.  PCSK9: a convertase that coordinates LDL catabolism Published, JLR Papers in Press, November 19, 2008. , 2009, Journal of Lipid Research.

[83]  Alnawaz Rehemtulla,et al.  Inhibition of Furin/Proprotein Convertase-catalyzed Surface and Intracellular Processing by Small Molecules* , 2009, The Journal of Biological Chemistry.

[84]  S. Humphries,et al.  Commentary PCSK9 variants: A new database. , 2009, Atherosclerosis.

[85]  I. Lindberg,et al.  Synthetic Small-Molecule Prohormone Convertase 2 Inhibitors , 2009, Molecular Pharmacology.

[86]  M. Mbikay,et al.  Proprotein convertase subtilisin/kexin type 4 in mammalian fertility: a review. , 2009, Human reproduction update.

[87]  D. Cox,et al.  Comprehensive Whole-Genome and Candidate Gene Analysis for Response to Statin Therapy in the Treating to New Targets (TNT) Cohort , 2009, Circulation. Cardiovascular genetics.

[88]  N. Seidah.  PCSK9 as a therapeutic target of dyslipidemia. , 2009, Expert opinion on therapeutic targets.

[89]  D. Banerjee.  Novel targets in cancer therapy. , 2009, Current pharmaceutical biotechnology.

[90]  L. Bernier,et al.  A new method for measurement of total plasma PCSK 9 : clinical applications , 2009 .

[91]  Y. Nie,et al.  Differential regulation of prohormone convertase 1/3, prohormone convertase 2 and phosphorylated cyclic-AMP-response element binding protein by short-term and long-term morphine treatment: Implications for understanding the “switch” to opiate addiction , 2008, Neuroscience.

[92]  D. Constam,et al.  Cripto recruits Furin and PACE4 and controls Nodal trafficking during proteolytic maturation , 2008, The EMBO journal.

[93]  D. Griggs,et al.  Proprotein convertase activation of aggrecanases in cartilage in situ. , 2008, Archives of biochemistry and biophysics.

[94]  Y. Belkaid,et al.  T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance , 2008, Nature.

[95]  Jonathan C. Cohen,et al.  Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptor , 2008, Proceedings of the National Academy of Sciences.

[96]  I. Wang,et al.  Pharmacologic Inhibition of Site 1 Protease Activity Inhibits Sterol Regulatory Element-Binding Protein Processing and Reduces Lipogenic Enzyme Gene Expression and Lipid Synthesis in Cultured Cells and Experimental Animals , 2008, Journal of Pharmacology and Experimental Therapeutics.

[97]  A. Roebroek,et al.  Role of furin in granular acidification in the endocrine pancreas: Identification of the V-ATPase subunit Ac45 as a candidate substrate , 2008, Proceedings of the National Academy of Sciences.

[98]  Robert Langer,et al.  Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates , 2008, Proceedings of the National Academy of Sciences.

[99]  N. Seidah,et al.  Inhibition of Chikungunya Virus Infection in Cultured Human Muscle Cells by Furin Inhibitors , 2008, Journal of Biological Chemistry.

[100]  Annik Prat,et al.  Proprotein convertase subtilisin/kexin type 9 (PCSK9): Hepatocyte‐specific low‐density lipoprotein receptor degradation and critical role in mouse liver regeneration , 2008, Hepatology.

[101]  T. Hansen,et al.  Common nonsynonymous variants in PCSK1 confer risk of obesity , 2008, Nature Genetics.

[102]  N. Seidah,et al.  Regulation of prohepcidin processing and activity by the subtilisin-like proprotein convertases Furin, PC5, PACE4 and PC7 , 2008, Gut.

[103]  Steve D. M. Brown,et al.  VACTERL/caudal regression/Currarino syndrome-like malformations in mice with mutation in the proprotein convertase Pcsk5. , 2008, Genes & development.

[104]  A. Prat,et al.  The activation and physiological functions of the proprotein convertases. , 2008, The international journal of biochemistry & cell biology.

[105]  J. Creemers,et al.  Knock-out mouse models of proprotein convertases: unique functions or redundancy? , 2008, Frontiers in bioscience : a journal and virtual library.

[106]  A. Roebroek,et al.  MMTV-cre-mediated fur inactivation concomitant with PLAG1 proto-oncogene activation delays salivary gland tumorigenesis in mice. , 2008, International journal of oncology.

[107]  A. Prat,et al.  In vivo functions of the proprotein convertase PC5/6 during mouse development: Gdf11 is a likely substrate , 2008, Proceedings of the National Academy of Sciences.

[108]  B. Ross,et al.  A small-molecule furin inhibitor inhibits cancer cell motility and invasiveness. , 2008, Neoplasia.

[109]  N. Seidah,et al.  Cell-surface processing of extracellular human immunodeficiency virus type 1 Vpr by proprotein convertases. , 2008, Virology.

[110]  J. Deisenhofer,et al.  Molecular basis for LDL receptor recognition by PCSK9 , 2008, Proceedings of the National Academy of Sciences.

[111]  A. Prat,et al.  The Proprotein Convertase PCSK9 Induces the Degradation of Low Density Lipoprotein Receptor (LDLR) and Its Closest Family Members VLDLR and ApoER2* , 2008, Journal of Biological Chemistry.

[112]  N. Seidah,et al.  The Regulated Cell Surface Zymogen Activation of the Proprotein Convertase PC5A Directs the Processing of Its Secretory Substrates* , 2008, Journal of Biological Chemistry.

[113]  N. Seidah,et al.  Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells. , 2008, The Journal of clinical investigation.

[114]  N. Seidah,et al.  Proprotein convertases as therapeutic targets. , 2008, Expert opinion on therapeutic targets.

[115]  S. Davies,et al.  Site-1 protease is essential for endochondral bone formation in mice. , 2007, The Journal of cell biology.

[116]  Satyan Chintawar,et al.  Gene set enrichment analysis reveals several globally affected pathways due to SKI-1/S1P inhibition in HepG2 cells. , 2007, DNA and cell biology.

[117]  R. Steinman,et al.  Dendritic cells: Understanding immunogenicity , 2007, European journal of immunology.

[118]  Fabien Calvo,et al.  Opposing function of the proprotein convertases furin and PACE4 on breast cancer cells' malignant phenotypes: role of tissue inhibitors of metalloproteinase-1. , 2007, Cancer research.

[119]  N. Seidah,et al.  The Proprotein Convertase SKI-1/S1P , 2007, Journal of Biological Chemistry.

[120]  S. O’Rahilly,et al.  Hyperphagia and early-onset obesity due to a novel homozygous missense mutation in prohormone convertase 1/3. , 2007, The Journal of clinical endocrinology and metabolism.

[121]  J. Horton,et al.  Catalytic Activity Is Not Required for Secreted PCSK9 to Reduce Low Density Lipoprotein Receptors in HepG2 Cells* , 2007, Journal of Biological Chemistry.

[122]  John A. Young,et al.  Anthrax toxin: receptor binding, internalization, pore formation, and translocation. , 2007, Annual review of biochemistry.

[123]  Annik Prat,et al.  The Cellular Trafficking of the Secretory Proprotein Convertase PCSK9 and Its Dependence on the LDLR , 2007, Traffic.

[124]  Xiayang Qiu,et al.  Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia , 2007, Nature Structural &Molecular Biology.

[125]  A. Prat,et al.  The proprotein convertases are potential targets in the treatment of dyslipidemia , 2007, Journal of Molecular Medicine.

[126]  Jonathan C. Cohen,et al.  Molecular biology of PCSK9: its role in LDL metabolism. , 2007, Trends in biochemical sciences.

[127]  N. Seidah,et al.  Stepwise posttranslational processing of progrowth hormone-releasing hormone (proGHRH) polypeptide by furin and PC1 , 2004, Endocrine.

[128]  R. Ramponi,et al.  Clinical applications , 2007, Lasers in Medical Science.

[129]  S. Millis,et al.  Synthetic small molecule furin inhibitors derived from 2,5-dideoxystreptamine , 2006, Proceedings of the National Academy of Sciences.

[130]  N. Seidah,et al.  The Proprotein Convertase (PC) PCSK9 Is Inactivated by Furin and/or PC5/6A , 2006, Journal of Biological Chemistry.

[131]  N. Seidah,et al.  Increased stress-induced analgesia in mice lacking the proneuropeptide convertase PC2 , 2006, Neuroscience Letters.

[132]  N. Seidah,et al.  Proprotein convertases: lessons from knockouts , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[133]  N. Seidah,et al.  The Proprotein Convertase SKI-1/S1P , 2006, Journal of Biological Chemistry.

[134]  A. Prat,et al.  The proprotein convertases and their implication in sterol and/or lipid metabolism , 2006, Biological chemistry.

[135]  G. Thomas,et al.  Identification of a pH Sensor in the Furin Propeptide That Regulates Enzyme Activation* , 2006, Journal of Biological Chemistry.

[136]  N. Gekakis,et al.  Obesity, hyperphagia and increased metabolic efficiency in Pc1 mutant mice. , 2006, Human molecular genetics.

[137]  Leiv Ose,et al.  Missense Mutations in the PCSK9 Gene Are Associated With Hypocholesterolemia and Possibly Increased Response to Statin Therapy , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[138]  N. Tanphaichitr,et al.  Sperm from Mice Genetically Deficient for the PCSK4 Proteinase Exhibit Accelerated Capacitation, Precocious Acrosome Reaction, Reduced Binding to Egg Zona Pellucida, and Impaired Fertilizing Ability1 , 2006, Biology of reproduction.

[139]  Jonathan C. Cohen,et al.  A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol. , 2006, American journal of human genetics.

[140]  Joseph L. Goldstein,et al.  Protein Sensors for Membrane Sterols , 2006, Cell.

[141]  A. Prat,et al.  Deletion of the Gene Encoding Proprotein Convertase 5/6 Causes Early Embryonic Lethality in the Mouse , 2006, Molecular and Cellular Biology.

[142]  L. Pegg,et al.  ADAMTS-4 (aggrecanase-1): N-terminal activation mechanisms. , 2005, Archives of biochemistry and biophysics.

[143]  M. Briel,et al.  Statin therapy for prevention and treatment of acute and chronic cardiovascular disease: update on recent trials and metaanalyses , 2005, Current opinion in lipidology.

[144]  S. Horswell,et al.  Severe Hypercholesterolemia in Four British Families With the D374Y Mutation in the PCSK9 Gene: Long-Term Follow-Up and Treatment Response , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[145]  N. Seidah,et al.  Proprotein Covertases Are Responsible for Proteolysis and Inactivation of Endothelial Lipase* , 2005, Journal of Biological Chemistry.

[146]  N. Seidah,et al.  The cysteine-rich domain of the secreted proprotein convertases PC5A and PACE4 functions as a cell surface anchor and interacts with tissue inhibitors of metalloproteinases. , 2005, Molecular biology of the cell.

[147]  D. Bassi,et al.  Proprotein convertases: “Master switches” in the regulation of tumor growth and progression , 2005, Molecular carcinogenesis.

[148]  T. Komiyama,et al.  Protection from Anthrax Toxin-Mediated Killing of Macrophages by the Combined Effects of Furin Inhibitors and Chloroquine , 2005, Antimicrobial Agents and Chemotherapy.

[149]  A. Basak,et al.  Role of pro-IGF-II processing by proprotein convertase 4 in human placental development. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[150]  D. Steiner,et al.  Strain-dependent influences on the hypothalamo-pituitary-adrenal axis profoundly affect the 7B2 and PC2 null phenotypes. , 2005, Endocrinology.

[151]  N. Seidah,et al.  Human carcinoma cell growth and invasiveness is impaired by the propeptide of the ubiquitous proprotein convertase furin. , 2005, Cancer research.

[152]  N. Seidah,et al.  Dual regulation of the LDL receptor--some clarity and new questions. , 2005, Cell metabolism.

[153]  R. Hammer,et al.  Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[154]  E. Fisher,et al.  Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[155]  Alexander Pertsemlidis,et al.  Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9 , 2005, Nature Genetics.

[156]  I. Lindberg,et al.  Proprotein convertase models based on the crystal structures of furin and kexin: explanation of their specificity. , 2005, Journal of molecular biology.

[157]  A. Lauwers,et al.  Limited Redundancy of the Proprotein Convertase Furin in Mouse Liver* , 2004, Journal of Biological Chemistry.

[158]  Jay D. Horton,et al.  Post-transcriptional Regulation of Low Density Lipoprotein Receptor Protein by Proprotein Convertase Subtilisin/Kexin Type 9a in Mouse Liver* , 2004, Journal of Biological Chemistry.

[159]  A. Prat,et al.  NARC-1/PCSK9 and Its Natural Mutants , 2004, Journal of Biological Chemistry.

[160]  L. Bernier,et al.  Statins Upregulate PCSK9, the Gene Encoding the Proprotein Convertase Neural Apoptosis-Regulated Convertase-1 Implicated in Familial Hypercholesterolemia , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[161]  M. Chrétien,et al.  In vitro elucidation of substrate specificity and bioassay of proprotein convertase 4 using intramolecularly quenched fluorogenic peptides. , 2004, The Biochemical journal.

[162]  J. Breslow,et al.  Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[163]  Michael D. Schneider,et al.  BMP10 is essential for maintaining cardiac growth during murine cardiogenesis , 2004, Development.

[164]  N. Seidah,et al.  Development of Protein-based Inhibitors of the Proprotein of Convertase SKI-1/S1P , 2004, Journal of Biological Chemistry.

[165]  Xiaorong Zhu,et al.  Furin and prohormone convertase 1/3 are major convertases in the processing of mouse pro-growth hormone-releasing hormone. , 2004, Endocrinology.

[166]  R. Siezen,et al.  Furin is a subtilisin-like proprotein processing enzyme in higher eukaryotes , 1990, Molecular Biology Reports.

[167]  A. Prat,et al.  ZYMOGEN CLEAVAGE AND EFFECTS ON THE LOW DENSITY LIPOPROTEIN (LDL) RECEPTOR AND LDL CHOLESTEROL , 2004 .

[168]  M. Skolnick,et al.  A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree , 2004, Human Genetics.

[169]  B. Ozenberger,et al.  Functional characterization of Narc 1, a novel proteinase related to proteinase K. , 2003, Archives of biochemistry and biophysics.

[170]  T. Wagner,et al.  Site-1 protease is required for cartilage development in zebrafish , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[171]  X. Puente,et al.  Human and mouse proteases: a comparative genomic approach , 2003, Nature Reviews Genetics.

[172]  J. Weissenbach,et al.  Mutations in PCSK9 cause autosomal dominant hypercholesterolemia , 2003, Nature Genetics.

[173]  K. Ishimura,et al.  Secretory proprotein convertases PACE4 and PC6A are heparin-binding proteins which are localized in the extracellular matrix. Potential role of PACE4 in the activation of proproteins in the extracellular matrix. , 2003, Biochimica et biophysica acta.

[174]  A. Prat,et al.  The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[175]  Robert Huber,et al.  The crystal structure of the proprotein processing proteinase furin explains its stringent specificity , 2003, Nature Structural Biology.

[176]  G. Thomas,et al.  Furin at the cutting edge: From protein traffic to embryogenesis and disease , 2002, Nature Reviews Molecular Cell Biology.

[177]  A. Prat,et al.  Precursor convertases in the secretory pathway, cytosol and extracellular milieu. , 2002, Essays in biochemistry.

[178]  A. Beaudet,et al.  Altered processing of the neurotensin/neuromedin N precursor in PC2 knock down mice: a biochemical and immunohistochemical study , 2002, Journal of neurochemistry.

[179]  Chunling Zhang,et al.  Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[180]  L. Orci,et al.  Severe block in processing of proinsulin to insulin accompanied by elevation of des-64,65 proinsulin intermediates in islets of mice lacking prohormone convertase 1/3 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[181]  N. Seidah,et al.  Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy. , 2002, The American journal of pathology.

[182]  N. Seidah,et al.  Biosynthesis and Cellular Trafficking of the Convertase SKI-1/S1P , 2002, The Journal of Biological Chemistry.

[183]  R. Hammer,et al.  Decreased lipid synthesis in livers of mice with disrupted Site-1 protease gene , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[184]  N. Seidah,et al.  The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[185]  Yoshihiro Kawaoka,et al.  Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses , 2001, Science.

[186]  A. Prat,et al.  Inhibition of Proprotein Convertases Is Associated with Loss of Growth and Tumorigenicity of HT-29 Human Colon Carcinoma Cells , 2001, The Journal of Biological Chemistry.

[187]  L. Orci,et al.  Severe Defect in Proglucagon Processing in Islet A-cells of Prohormone Convertase 2 Null Mice* , 2001, The Journal of Biological Chemistry.

[188]  N. Seidah,et al.  Neuroendocrine secretory protein 7B2: structure, expression and functions. , 2001, The Biochemical journal.

[189]  Paul Scherz,et al.  Functional analysis of secreted and transmembrane proteins critical to mouse development , 2001, Nature Genetics.

[190]  F. Dorner,et al.  'Shed' furin: mapping of the cleavage determinants and identification of its C-terminus. , 2001, The Biochemical journal.

[191]  A. Arimura,et al.  Prohormone Convertase PC4 Processes the Precursor of PACAP in the Testis , 2000, Annals of the New York Academy of Sciences.

[192]  X. Chen,et al.  ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. , 2000, Molecular cell.

[193]  E. Decroly,et al.  Maturation of HIV envelope glycoprotein precursors by cellular endoproteases. , 2000, Biochimica et biophysica acta.

[194]  A. Polonskaia,et al.  Defective Prodynorphin Processing in Mice Lacking Prohormone Convertase PC2 , 2000, Journal of neurochemistry.

[195]  D. Constam,et al.  SPC4/PACE4 regulates a TGFbeta signaling network during axis formation. , 2000, Genes & development.

[196]  G. Thomas,et al.  The PC6B cytoplasmic domain contains two acidic clusters that direct sorting to distinct trans-Golgi network/endosomal compartments. , 2000, Molecular biology of the cell.

[197]  D. Constam,et al.  Tissue-specific requirements for the proprotein convertase furin/SPC1 during embryonic turning and heart looping. , 2000, Development.

[198]  N. Seidah,et al.  The Prosegments of Furin and PC7 as Potent Inhibitors of Proprotein Convertases , 1999, The Journal of Biological Chemistry.

[199]  N. Seidah,et al.  Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides 1 Published on the World Wide Web on 17 August 1999. 1 , 1999, Brain Research.

[200]  P. Espenshade,et al.  Autocatalytic Processing of Site-1 Protease Removes Propeptide and Permits Cleavage of Sterol Regulatory Element-binding Proteins* , 1999, The Journal of Biological Chemistry.

[201]  Se-Jin Lee,et al.  Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11 , 1999, Nature Genetics.

[202]  T. Moehring,et al.  Endoprotease PACE4 is Ca2+-dependent and temperature-sensitive and can partly rescue the phenotype of a furin-deficient cell strain. , 1999, The Biochemical journal.

[203]  P. Leder,et al.  The Neuroendocrine Protein 7B2 Is Required for Peptide Hormone Processing In Vivo and Provides a Novel Mechanism for Pituitary Cushing’s Disease , 1999, Cell.

[204]  H. Klenk,et al.  Understanding influenza virus pathogenicity. , 1999, Trends in microbiology.

[205]  N. Seidah,et al.  Mammalian subtilisin/kexin isozyme SKI-1: A widely expressed proprotein convertase with a unique cleavage specificity and cellular localization. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[206]  N. Seidah,et al.  Enzymic characterization in vitro of recombinant proprotein convertase PC4. , 1999, The Biochemical journal.

[207]  D. Constam,et al.  Failure of ventral closure and axial rotation in embryos lacking the proprotein convertase Furin. , 1998, Development.

[208]  J. T. Buckley,et al.  The Pore-forming Toxin Proaerolysin Is Activated by Furin* , 1998, The Journal of Biological Chemistry.

[209]  J. Goldstein,et al.  Isolation of Cholesterol-requiring Mutant Chinese Hamster Ovary Cells with Defects in Cleavage of Sterol Regulatory Element-binding Proteins at Site 1* , 1998, The Journal of Biological Chemistry.

[210]  P. Espenshade,et al.  Molecular identification of the sterol-regulated luminal protease that cleaves SREBPs and controls lipid composition of animal cells. , 1998, Molecular cell.

[211]  L. Orci,et al.  Incomplete Processing of Proinsulin to Insulin Accompanied by Elevation of Des-31,32 Proinsulin Intermediates in Islets of Mice Lacking Active PC2* , 1998, The Journal of Biological Chemistry.

[212]  A. Roebroek,et al.  Biosynthesis, Distinct Post-translational Modifications, and Functional Characterization of Lymphoma Proprotein Convertase* , 1997, The Journal of Biological Chemistry.

[213]  A. Rehemtulla,et al.  A role for PACE4 in the proteolytic activation of anthrax toxin protective antigen , 1997, Infection and immunity.

[214]  S. O’Rahilly,et al.  Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene , 1997, Nature Genetics.

[215]  E. Simpson,et al.  Impaired fertility in mice deficient for the testicular germ-cell protease PC4. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[216]  L. Orci,et al.  Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[217]  J. Leunissen,et al.  Subtilases: The superfamily of subtilisin‐like serine proteases , 1997, Protein science : a publication of the Protein Society.

[218]  N. Seidah,et al.  Comparative analysis of expression of the proprotein convertases furin, PACE4, PC1 and PC2 in human lung tumours. , 1997, British Journal of Cancer.

[219]  D. Constam,et al.  SPC4, SPC6, and the novel protease SPC7 are coexpressed with bone morphogenetic proteins at distinct sites during embryogenesis , 1996, The Journal of cell biology.

[220]  N. Seidah,et al.  cDNA structure, tissue distribution, and chromosomal localization of rat PC7, a novel mammalian proprotein convertase closest to yeast kexin-like proteinases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[221]  T. Martin,et al.  PC8 [corrected], a new member of the convertase family. , 1996, The Biochemical journal.

[222]  T. Lister,et al.  A new member of the proprotein convertase gene family (LPC) is located at a chromosome translocation breakpoint in lymphomas. , 1996, Cancer research.

[223]  A Wlodawer,et al.  New database. , 1996, Science.

[224]  D. Vieau,et al.  Distinct mRNA expression of the highly homologous convertases PC5 and PACE4 in the rat brain and pituitary , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[225]  N. Seidah,et al.  Electron microscopic immunocytochemical evidence for the involvement of the convertases PC1 and PC2 in the processing of proinsulin in pancreatic beta-cells. , 1995, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[226]  K. Klimpel,et al.  Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases , 1995, Infection and immunity.

[227]  N. Seidah,et al.  The neuroendocrine precursor 7B2 is a sulfated protein proteolytically processed by a ubiquitous furin-like convertase. , 1994, The Journal of biological chemistry.

[228]  H. Klenk,et al.  Host cell proteases controlling virus pathogenicity. , 1994, Trends in microbiology.

[229]  N. Seidah,et al.  Pro-protein convertases of subtilisin/kexin family. , 1994, Methods in enzymology.

[230]  L. Thomas,et al.  Inhibition of HIV-1 gp160-dependent membrane fusion by a furin-directed alpha 1-antitrypsin variant. , 1993, The Journal of biological chemistry.

[231]  K Nakayama,et al.  Identification of an isoform with an extremely large Cys‐rich region of PC6, a Kex2‐like processing endoprotease , 1993, FEBS letters.

[232]  M Chrétien,et al.  cDNA structure of the mouse and rat subtilisin/kexin-like PC5: a candidate proprotein convertase expressed in endocrine and nonendocrine cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[233]  T Watanabe,et al.  Identification and functional expression of a new member of the mammalian Kex2-like processing endoprotease family: its striking structural similarity to PACE4. , 1993, Journal of biochemistry.

[234]  H. Klenk,et al.  Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gpl60 , 1992, Nature.

[235]  M Chrétien,et al.  Testicular expression of PC4 in the rat: molecular diversity of a novel germ cell-specific Kex2/subtilisin-like proprotein convertase. , 1992, Molecular endocrinology.

[236]  N. Seidah,et al.  Proprotein conversion is determined by a multiplicity of factors including convertase processing, substrate specificity, and intracellular environment. Cell type-specific processing of human prorenin by the convertase PC1. , 1992, The Journal of biological chemistry.

[237]  N. Seidah,et al.  Distribution and regulation of the prohormone convertases PC1 and PC2 in the rat pituitary. , 1992, Molecular endocrinology.

[238]  Richard I. Joh,et al.  Identification of a second human subtilisin-like protease gene in the fes/fps region of chromosome 15. , 1991, DNA and cell biology.

[239]  K. Nakayama,et al.  Cloning and functional expression of a novel endoprotease involved in prohormone processing at dibasic sites. , 1991, Journal of biochemistry.

[240]  D. Steiner,et al.  Identification of a cDNA encoding a second putative prohormone convertase related to PC2 in AtT20 cells and islets of Langerhans. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[241]  M. Marcinkiewicz,et al.  Mammalian neural and endocrine pro-protein and pro-hormone convertases belonging to the subtilisin family of serine proteinases. , 1991, Enzyme.

[242]  M Chrétien,et al.  cDNA sequence of two distinct pituitary proteins homologous to Kex2 and furin gene products: tissue-specific mRNAs encoding candidates for pro-hormone processing proteinases. , 1990, DNA and cell biology.

[243]  D. Steiner,et al.  Identification of a human insulinoma cDNA encoding a novel mammalian protein structurally related to the yeast dibasic processing protease Kex2. , 1990, The Journal of biological chemistry.

[244]  N. Seidah,et al.  cDNA sequence of two distinct pituitary proteins homologous to Kex2 and furin gene products: tissue-specific mRNAs encoding candidates for pro-hormone processing proteinases. , 1990, DNA and cell biology.

[245]  A. V. D. van den Ouweland,et al.  Nucleotide sequence analysis of the human fur gene. , 1989, Nucleic acids research.

[246]  J. Thorner,et al.  Yeast prohormone processing enzyme (KEX2 gene product) is a Ca2+-dependent serine protease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[247]  T. Nakamura,et al.  Yeast KEX2 genes encodes an endopeptidase homologous to subtilisin-like serine proteases. , 1988, Biochemical and biophysical research communications.

[248]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[249]  J. Thorner,et al.  Isolation of the putative structural gene for the lysine-arginine-cleaving endopeptidase required for processing of yeast prepro-α-factor , 1984, Cell.

[250]  N. Seidah,et al.  Isolation and NH2‐terminal sequence of a novel porcine anterior pituitary polypeptide , 1982, FEBS letters.

[251]  J. Kraut,et al.  Structure of subtilisin BPN' at 2.5 angström resolution. , 1969, Nature.